Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy

Nephrology

Volumn 17, Issue 5, 2012, Pages 480-487

  Yu, Ze Yan ^a   Chen, Li Sheng ^b   Zhang, Lei Chang ^b   Zhou, Tian Biao ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

angiotensin converting enzyme; diabetic nephropathy; end stage renal disease; insertion deletion gene polymorphism; meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CAUCASIAN; COCHRANE LIBRARY; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EMBASE; ETHNICITY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INDEL MUTATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; KIDNEY FAILURE, CHRONIC; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84862995604     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01592.x     Document Type: Article

References (48)

1. Hoffmann F, Haastert B, Koch M, Giani G, Glaeske G, Icks A,. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol. Dial. Transplant. 2011; 26: 1634-40.
2. Fassett RG, Robertson IK, Mace R, Youl L, Challenor S, Bull R,. Palliative care in end-stage kidney disease. Nephrology (Carlton) 2011; 16: 4-12.
3. Grace BS, Clayton P, McDonald SP,. Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy. Nephrology (Carlton) 2012; 17: 76-84.
4. McDonough CW, Palmer ND, Hicks PJ, et al,. A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int. 2011; 79: 563-72.
5. Alkhalaf A, Bakker SJ, Bilo HJ, et al,. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus. Diabetologia 2010; 53: 2562-68.
6. El-Din BS, Hamdy SM,. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. Ren. Fail. 2011; 33: 878-84.
7. Hubacek JA, Viklicky O, Dlouha D, et al,. The FTO gene polymorphism is associated with end-stage renal disease: Two large independent case-control studies in a general population. Nephrol. Dial. Transplant. 2012; 27: 1030-5.
8. Pereira TV, Nunes AC, Rudnicki M, et al,. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: A meta-analysis. Nephrol. Dial. Transplant. 2006; 21: 3155-63. (Pubitemid 44567088)
9. Settin A, Elbaz R, Abbas A, Abd-Al-Samad A, Noaman A,. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction. J. Renin Angiotensin Aldosterone Syst. 2009; 10: 96-100.
10. Qin YH, Zhou TB, Su LN, Lei FY, Zhao YJ, Huang WF,. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: A meta-analysis of 13 randomized controlled trials. Blood Coagul. Fibrinolysis 2010; 21: 713-21.
11. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ,. ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: A meta-analysis. PLoS ONE 2011; 6: e19599.
12. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
13. Egger M, Davey SG, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
14. Doria A, Warram JH, Krolewski AS,. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-95.
15. Oh TG, Shin CS, Park KS, et al,. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients. Korean J. Intern. Med. 1996; 11: 133-37.
16. Marre M, Jeunemaitre X, Gallois Y, et al,. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J. Clin. Invest. 1997; 99: 1585-95. (Pubitemid 27163809)
17. Miura J, Uchigata Y, Yokoyama H, Omori Y, Iwamoto Y,. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res. Clin. Pract. 1999; 45: 41-9. (Pubitemid 29356123)
18. Azar ST, Zalloua PA, Medlej R, Halabi G,. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics. Endocr. Res. 2001; 27: 99-108. (Pubitemid 32565581)
19. Movva S, Alluri RV, Komandur S, et al,. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J. Diabetes Complications 2007; 21: 237-41. (Pubitemid 47002317)
20. Ahluwalia TS, Ahuja M, Rai TS, et al,. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol. 2009; 28: 141-50.
21. Hadjadj S, Fumeron F, Roussel R, et al,. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: Results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies. Diabetes Care 2008; 31: 1847-52.
22. Sakka Y, Babazono T, Sato A, Ujihara N, Iwamoto Y,. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease. Diabetes Res. Clin. Pract. 2004; 64: 41-9. (Pubitemid 38249456)
23. Jacobsen PK,. Preventing end stage renal disease in diabetic patients-genetic aspect (part I). J. Renin Angiotensin Aldosterone Syst. 2005; 6: 1-14. (Pubitemid 40796843)
24. Yoshida H, Kuriyama S, Atsumi Y, et al,. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int. 1996; 50: 657-64. (Pubitemid 26274398)
25. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E,. Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol. Dial. Transplant. 1997; 12: 427-9. (Pubitemid 27105613)
26. Ringel J, Beige J, Kunz R, Distler A, Sharma AM,. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997; 40: 193-9. (Pubitemid 27060292)
27. Vleming LJ, van der Pijl JW, Lemkes HH, et al,. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin. Nephrol. 1999; 51: 133-40. (Pubitemid 29116414)
28. Wong TY, Chan JC, Poon E, Li PK,. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am. J. Kidney Dis. 1999; 33: 1064-70. (Pubitemid 29252676)
29. Gohda T, Makita Y, Shike T, et al,. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin. Nephrol. 2001; 56: 475-80. (Pubitemid 33133605)
30. Ha SK, Park HC, Park HS, et al,. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: Effect of ACE gene DD on the progression of diabetic nephropathy. Am. J. Kidney Dis. 2003; 41: 943-9. (Pubitemid 36532128)
31. Chang HR, Cheng CH, Shu KH, Chen CH, Lian JD, Wu MY,. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J. Chin. Med. Assoc. 2003; 66: 51-6.
32. Park HC, Choi SR, Kim BS, et al,. Polymorphism of the ACE Gene in dialysis patients: Overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med. J. 2005; 46: 779-87. (Pubitemid 43085180)
33. Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A,. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol. Dial. Transplant. 2006; 21: 979-83.
34. Jayapalan JJ, Muniandy S, Chan SP,. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J. Hum. Genet. 2010; 16: 78-86.
35. Zsom M, Fulop T, Zsom L, Barath A, Maroti Z, Endreffy E,. Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial. Int. 2011; 15: 501-8.
36. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ,. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and susceptibility of minimal change nephrotic syndrome: A meta-analysis. Int. J. Nephrol. 2011; 2011: 360357.
37. Zhou TB, Qin YH, Su LN, et al,. Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroid-resistant nephrotic syndrome for children: A genetic association study and meta-analysis. Ren. Fail. 2011; 33: 741-8.
38. Zhou TB, Qin YH, Ou C, et al,. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and steroid-sensitive nephrotic syndrome in children. J. Renin Angiotensin Aldosterone Syst. 2012; 13: 175-83.
39. Zhou TB, Ou C, Qin YH, et al,. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: A meta-analysis. J. Renin Angiotensin Aldosterone Syst. 2011; 12: 601-10.
40. Campbell KN, Raij L, Mundel P,. Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr. Diabetes Rev. 2011; 7: 3-7.
41. Ulrich C, Heine GH, Seibert E, Fliser D, Girndt M,. Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2010; 25: 2265-72.
42. Jafar TH, Stark PC, Schmid CH, et al,. Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann. Intern. Med. 2003; 139: 244-52.
43. Jafar TH, Stark PC, Schmid CH, et al,. The effect of angiotensin- converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int. 2005; 67: 265-71. (Pubitemid 40019248)
44. Ruggenenti P, Cravedi P, Remuzzi G,. The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat. Rev. Nephrol. 2010; 6: 319-30.
45. Tripathi G, Dharmani P, Khan F, Sharma RK, Pandirikkal V, Agrawal S,. High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMC Nephrol. 2006; 7: 15.
46. Lee YT, Chiu HC, Su HM, et al,. The D allele of angiotensin-converting enzyme polymorphism as a predictor of renal function decline over 4 years in an apparently healthy Chinese population aged 60 and older. J. Am. Geriatr. Soc. 2008; 56: 718-23.
47. Huang HD, Lin FJ, Li XJ, Wang LR, Jiang GR,. Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. Chin. Med. J. 2010; 123: 3238-42.
48. Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN,. Renin-angiotensin system polymorphisms: A risk factor for progression to end-stage renal disease in vesicoureteral reflux patients. Ren. Fail. 2009; 31: 196-200.